Treatment setting and buprenorphine discontinuation: an analysis of multi-state insurance claims

CONCLUSION: Buprenorphine discontinuation is high across outpatient PCP, psychiatry, and SUD treatment facility settings, with potentially lower treatment retention among Medicaid enrollees receiving care from SUD facilities and PCPs.PMID:38493109 | DOI:10.1186/s13722-024-00450-0

Source: Addiction Science and Clinical Practice - March 17, 2024 Category: Addiction Authors: Kevin Y Xu Alex K Gertner Shelly F Greenfield Arthur Robin Williams Richard A Grucza Source Type: research